已收盤 10-10 16:00:00 美东时间
-2.580
-0.61%
今日重点评级关注:HC Wainwright & Co.:维持Inventiva"买入"评级,目标价从20美元升至24美元;摩根大通:维持BioMarin Pharmaceutical"超配"评级,目标价从116美元升至119美元
10-10 11:36
Truist Securities analyst Keith Hughes maintains TopBuild (NYSE:BLD) with a Hold and raises the price target from $370 to $390.
10-09 22:49
美股周三尾盘,绝缘材料安装服务商TopBuild(BLD)股价上涨8%,此前公司同意以10亿美元现金收购Specialty Products and In...
10-09 03:20
TopBuild stock climbed on Wednesday after the company revealed a $1 billion pur...
10-08 21:15
TopBuild acquired SPI for $1 billion, enhancing its leadership in specialty distribution, geographic reach, and mechanical insulation capabilities. The transaction, which excludes SPI’s MBI business, is immediately accretive with $35-$40 million in annual cost synergies expected. SPI generated $700 million in revenue and $75 million in EBITDA for the trailing twelve months. This acquisition strengthens TopBuild’s presence in non-cyclical markets ...
10-08 10:45
今日重点评级关注:HC Wainwright & Co.:维持GoldMining"买入"评级,目标价从3.25美元升至3.75美元;摩根士丹利:维持Crinetics Pharmaceuticals"超配"评级,目标价从65美元升至77美元
09-30 14:16
Evercore ISI Group analyst Stephen Kim maintains TopBuild (NYSE: BLD) with a In-Line and lowers the price target from $425 to $424.
09-29 23:06
TopBuild Corp. will host an Investor Day on December 9, 2025, in New York City. CEO Robert Buck, CFO Rob Kuhns, and senior leadership will discuss the company's business model, growth drivers, capital allocation, and financial targets. The event includes Q&A and lunch for in-person attendees, with live webcast and archived access available on the TopBuild website.
09-19 11:30
近日,百奥赛图(02315)公布与默克、Tubulis、IDEAYA的多项合作及研发进展引起市场关注,凸显其在抗体药物研发及创新递送技术领域的平台实力与国际合作...
09-18 11:36
An update from TopBuild ( ($BLD) ) is now available. On September 15, 2025, Top...
09-15 20:50